Solon, OH, United States of America

Afshin Dowlati

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Prognostic Predictions: The Work of Afshin Dowlati

Introduction

Afshin Dowlati is an accomplished inventor based in Solon, OH (US). He has made significant contributions to the field of medical imaging and cancer prognosis. His innovative work focuses on enhancing the predictive capabilities for patients suffering from small cell lung cancer (SCLC).

Latest Patents

Dowlati holds a patent for a groundbreaking invention titled "Combination of features from biopsies and scans to predict prognosis in SCLC." This patent involves a non-transitory computer-readable medium that stores computer-executable instructions. When executed, these instructions generate an imaging data set that combines both scan data and digitized biopsy data from patients with SCLC. The invention extracts scan-derived features and biopsy-derived features to calculate a radiomic-pathomic risk score (RPRS), which indicates the prognosis of the patient.

Career Highlights

Afshin Dowlati is currently employed by the United States Government as represented by the Department of Veterans Affairs. His work is pivotal in advancing the understanding of cancer prognosis through innovative imaging techniques. With a focus on integrating various data sources, Dowlati's contributions are helping to improve patient outcomes in oncology.

Collaborations

Dowlati collaborates with notable professionals in his field, including Anant Madabhushi and Cristian Barrera. Their combined expertise enhances the research and development of predictive models in cancer treatment.

Conclusion

Afshin Dowlati's innovative work in combining imaging data and biopsy results represents a significant advancement in cancer prognosis. His contributions are vital for improving the accuracy of predictions for patients with small cell lung cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…